Medical Devices Startups

Doktor24 operates the Kastélypark Klinika, a Hungarian orthopedic clinic providing sports and limb surgery along with post-operative rehabilitation, including NEAK-financed orthopedic surgeries. It serves patients and elite athletes from its clinic in Budapest, Hungary.

1 investor

Dolinnov is a pharmaceutical company developing next-generation painkillers based on a Precision Pump Modulator that targets the ion pump driving neuronal hyperexcitability rather than blocking ion channels. It focuses on treatments for extreme chronic pain and other serious diseases with significant unmet medical needs.

1 investor

Domus develops molecular testing platforms that perform nucleic acid detection in a single-step reaction across three deployment models: at-home rapid tests, clinic-based instruments, and central laboratory assays. The company serves clinical diagnostics and at-home testing markets with technology optimized for sensitivity, simplicity, and low cost.

1 investor

Dorsavi develops wearable sensor technology and video AI tools for analyzing human movement, serving clinical, athletic, workplace, and research settings. Its products are used to assess movement and reduce injury risk.

1 investor

Dotbase builds software that structures clinical documentation and links care data to patient outcomes in real time, mapping treatment decisions to their real-world impact. The product targets healthcare providers, addressing the large share of clinical data that remains unstructured.

1 investor

The company was founded to develop technology for people with disabilities. The team includes clinical researchers, hardware engineers, and machine learning specialists.

1 investor

Dovideq Medical develops medical equipment systems and related management software for healthcare facilities. EndoscopeManager is a data management platform that tracks equipment performance and ensures regulatory compliance.

1 investor

DP Bio Innovations is developing an implantable, bioresorbable medical device that regenerates a damaged esophagus inside the body, intended to treat patients with severe GERD/advanced Barrett's Esophagus, esophageal cancer, and pediatric esophageal defects. The device aims to avoid surgical reconstruction such as gastric pull-up and reduce treatment costs compared to the standard of care.

1 investor

Dr Agarwal provides eye care services and treatments, including advanced technology-based procedures for patients. It operates across India.

1 investor

DRC provides clear aligner orthodontic treatment for smile correction. The company serves customers in Singapore with certified medical orthodontic solutions.

1 investor

Draupnir Bio develops targeted protein degradation therapies using sortilin-based lysosome targeting chimeras to clear extracellular and membrane-bound protein aggregates in proteinopathies. The company, a spin-out from Aarhus University and Max-Planck Society, builds proprietary platform technology to treat diseases with significant unmet medical need.

1 investor

Dr. Mohan's is Asia's largest healthcare network specializing in diabetes treatment and complications management. The organization operates comprehensive diabetes care services across multiple facilities with over 33 years of clinical and research experience.

1 investor

DST develops allergy and food intolerance diagnostic products for medical laboratories and healthcare professionals, including laboratory tests and point-of-care testing systems. The company focuses on tailored diagnostic solutions for different geographic regions.

1 investor

DVLP is a biotechnology company developing vaccine platforms using artificial intelligence, synthetic biology, and immunology. The company appears to focus on next-generation vaccine development beyond mRNA technologies.

1 investor

DxLab develops multiplex molecular diagnostic technology (LAMP+) for rapid, low-cost point-of-care infectious disease testing, including its DxHub portable testing platform, DxTests, and ready-to-use LAMP master mixes. Founded by MIT and Harvard graduates, it serves public health applications such as Mpox and antimicrobial resistance detection.

1 investor

Dynamics VR develops VR therapy software and hardware packages for clinical settings. The company offers modular VR systems bundled with therapeutic software and training, designed for medical clinics and therapists.

1 investor

DYSIS Medical develops computer-aided imaging technology integrated with colposcopes to help healthcare professionals detect cervical lesions more efficiently. The company manufactures and markets medical devices for cervical cancer screening and diagnosis.

1 investor

EADERM develops pharmaceuticals and therapeutics for hair loss and skin disorders based on tissue stem cell aging and regeneration control technology. The company targets treatment and prevention of alopecia and age-related skin conditions through innovative approaches centered on cellular mechanisms rather than symptomatic relief.

1 investor

Eaglenos develops smart healthcare technologies, focusing on precision testing and personalized health management.

1 investor

Eaglet Eye develops corneal and scleral profiling technology for ophthalmological diagnostics. The company produces advanced topography systems used in eye care and clinical applications.

1 investor

Earflo develops a non-invasive home treatment device for negative middle ear pressure in children, addressing a common pediatric condition that affects millions of children annually. The product aims to help families avoid ear surgery while providing evidence-based symptom relief and long-term health benefits.

1 investor

Earli Point Health is a company that offers the EarliPoint System, an FDA-cleared medical device designed to aid clinicians in diagnosing and assessing autism spectrum disorder in children using objective measurement of looking behavior during video presentations, complementing traditional ABA therapy assessments.

1 investor

Early develops a home urinalysis system that pairs a clinical-grade electrochemical reader with disposable urine tests to screen for markers of serious conditions such as urinary tract cancers, diabetes, kidney disease, and heart disease risk, plus wellness markers, delivering results to an app in under five minutes. The consumer product is aimed at at-home early disease detection and is planned to launch in Spring 2027.

1 investor

EarlyDx develops non-invasive liquid biopsy tests aimed at early cancer detection and precision medicine. The company positions its tests as accurate and affordable diagnostics.

1 investor